Navigation Links
Amedica® Closes $30 Million Financing
Date:9/7/2010

SALT LAKE CITY, Sept. 7 /PRNewswire/ -- Amedica Corporation, a developer of a broad range of innovative, unique spine and total joint implants, announced that it has completed a $30 million financing.  The financing consists of $15 million in private equity and a debt facility of $15 million.  Zions First National Bank provided the debt facility, and Creation Capital of New York and Austin, Texas, acted as the placement agent for the private equity piece.  Creation Capital is an established banking concern that specializes in high-growth emerging health care technologies.

The proceeds from this financing will be used for expansion, mergers and acquisitions, sales and marketing support.  Ben Shappley, Chief Executive Officer, President and Director of Amedica stated, "We are pleased to complete this transaction that will enable and further sustain our substantial growth.  We are currently experiencing a challenging period in the capital markets and the overall struggling economy.  Our success in completing this and other recent strategic financings clearly speaks to the importance of our platform technologies, our vast intellectual property estate and investor confidence in the strength of our organization."

Amedica has completed transactions in excess of $100 million in the recent past to support and grow the company's technology assets and value.  Amedica has shown solid growth at a CAGR of 24% increase over the last six quarters in its spinal implant business.  

About Amedica:

Amedica Corporation is ISO 13485 certified and its products are FDA cleared and CE approved.  Amedica Corporation is an emerging orthopaedic implant company focused on using its silicon nitride ceramic and other technologies to develop and commercialize a broad range of innovative, unique spine and total joint implants for the growing orthopaedic device market.  It has brought to market various spinal implant products, while products under development include reconstructive hip and knee implants that represent a new standard of care in total joint implants based on superior performance, safety and efficacy.


'/>"/>
SOURCE Amedica Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Amedica® Receives Patent for Knee Prosthesis With Monoblock Silicon Nitride Ceramic Tibial Component
2. Amedica® Receives Patent for Hip Implant Using Monoblock Ceramic Technology
3. Warner Chilcott Completes Amendment to Existing Senior Secured Credit Facilities and Closes Senior Notes Offering; Company Declares Special Cash Dividend of $8.50 Per Share and Updates Full-Year 2010 Financial Guidance
4. International Research Team Closes In On Cause of Common Form of Muscular Dystrophy
5. SI-BONE, Inc. Closes $11.0 Million Financing Led by Skyline Ventures
6. Sangon & Bio Basic Inc. Closes $10 Million Round of Investment by Qiming Ventures
7. RoundTable Healthcare Partners Closes Two Funds
8. iPierian Closes $22 Million Series B Financing Led By Google Ventures
9. Micromet Closes $80.5 Million Public Offering of Common Stock
10. Cheetah Medical Closes $20 Million Series B Financing
11. Castle Access Closes Equity Capital Financing to Provide for Accelerated Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)...  ImaginAb Inc. today announced the appointment of Martyn Coombs ... , chairman of ImaginAb, said "At ImaginAb we have exciting science ... relevant to our business, particularly in commercializing and making step changes ... we can realize our potential." ... Mr. Coombs is a recognized industry leader in nuclear ...
(Date:3/22/2017)... 2017 Research and Markets has announced ... Market & Clinical Pipeline Insight 2022" drug pipelines to ... ... Pipeline Insight 2022 report gives comprehensive insight on clinical and ... check point inhibitors as main streamline drugs in the immunotherapy ...
(Date:3/22/2017)... LINCOLN, Mass. , March 22, 2017 /PRNewswire/ ... applying mechanistic modeling to drug research and development, ... QSP Day 2017.  QSP Day 2017 is a ... with the quantitative systems pharmacology (QSP) community. The ... mathematical modeling is de-risking and accelerating drug research ...
Breaking Medicine Technology:
(Date:3/22/2017)... ... 2017 , ... Wash Tower Ltd. has released a series of six viral ... world's first standalone constant pressure bidet. , The videos in the series titled "The ... as well as on its social media pages. , Each video stars Arthur ...
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... An intensive ... could occasionally transmit HIV, reports Leslie Norins, MD, PhD. He says investigating ... of domestically transmitted Zika virus and in new infections with HIV. , ...
(Date:3/22/2017)... ... March 22, 2017 , ... The ... research collaboration to translate advances in basic neuroscience at the BMRI labs into ... collaboration seeks to improve movement, vision, and cognition impaired by stroke, traumatic brain ...
(Date:3/22/2017)... ... March 22, 2017 , ... The ... north Jersey and the New York metropolitan region, is embarking on a cooperative ... homeless families. , At present, more than two and a half million children ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... planning, and related services to communities across eastern Texas, is announcing a charity ... providing meals to hungry children and adults. , Consistently a top-rated nonprofit ...
Breaking Medicine News(10 mins):